سعر بيتينفاك 0.5% شراب 100 مل 2024

Betenvac 0.5% (atenolol) oral syrup 100 ml; cardioselective beta-1 blocker marketed in Egypt by Sigma/Pharma Vision.

• Hypertension (ingredient-level indication for atenolol)Population: Adults (confirm syrup dosing on Egyptian label)DrugBank

• Atenolol is typically contraindicated in sinus bradycardia, greater than first-degree AV block, cardiogenic shock, and overt cardiac failure (ingredient-level beta-1 blocker labeling).General active-ingredient information · DrugBank

• Abrupt withdrawal of beta blockers may exacerbate angina; caution in reactive airway disease, diabetes (may mask hypoglycemia), and peri-operative settings.General active-ingredient information · DrugBank

• Beta blockers including atenolol have been associated with fetal growth restriction and neonatal bradycardia/hypoglycemia; use in pregnancy only if clearly needed (ingredient-level).General active-ingredient information · DrugBank

• Atenolol: Beta1-selective beta-adrenergic receptor blocker without membrane-stabilizing or intrinsic sympathomimetic activity; selectivity is not absolute and higher doses also inhibit beta2 receptors (US label).